Growth inhibitory effect of the human NIT2 gene and its allelic imbalance in cancers

FEBS Journal

Volumn 274, Issue 11, 2007, Pages 2946-2956

  Lin, Chun Hung ^a   Chung, Ming Yi ^a,b   Chen, Wen Bin ^a   Chien, Chin Hsiang ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

14 3 3 ; 14 3 3 ; Allelic imbalance; G2 M arrest; Human NIT2

Indexed keywords

MESSENGER RNA; NITRILASE; NITRILASE FAMILY MEMBER 2; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ALLELIC IMBALANCE; APOPTOSIS; ARTICLE; CANCER; CANCER TISSUE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN GENOME; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

14-3-3 PROTEINS; ACID ANHYDRIDE HYDROLASES; ALLELIC IMBALANCE; AMINOHYDROLASES; CELL PROLIFERATION; EXONUCLEASES; G2 PHASE; HELA CELLS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-AKT; SUBCELLULAR FRACTIONS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

MAMMALIA;

EID: 34249048074     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05828.x     Document Type: Article

References (24)

1. Pace HC Brenner C (2001) The nitrilase superfamily: classification, structure and function. Genome Biol 2, REVIEWS0001.
2. Bartling D, Seedorf M, Mithofer A Weiler EW (1992) Cloning and expression of an Arabidopsis nitrilase which can convert indole-3-acetonitrile to the plant hormone, indole-3-acetic acid. Eur J Biochem 205, 417 424.
3. Pekarsky Y, Campiglio M, Siprashvili Z, Druck T, Sedkov Y, Tillib S, Draganescu A, Wermuth P, Rothman JH, Huebner K et al. (1998) Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans. Proc Natl Acad Sci USA 95, 8744 8749.
4. Pace HC, Hodawadekar SC, Draganescu A, Huang J, Bieganowski P, Pekarsky Y, Croce CM Brenner C (2000) Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers. Curr Biol 10, 907 917.
5. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U et al. (1996) The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 85, 17 26.
6. Sevignani C, Calin GA, Cesari R, Sarti M, Ishii H, Yendamuri S, Vecchione A, Trapasso F Croce CM (2003) Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res 63, 1183 1187.
7. Semba S Huebner K (2006) Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression. Mol Cancer Res 4, 529 538.
8. Marcotte EM, Pellegrini M, Ng HL, Rice DW, Yeates TO Eisenberg D (1999) Detecting protein function and protein-protein interactions from genome sequences. Science 285, 751 753.
9. Semba S, Han SY, Qin HR, McCorkell KA, Iliopoulos D, Pekarsky Y, Druck T, Trapasso F, Croce CM Huebner K (2006) Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor. J Biol Chem 281, 28244 28253.
10. Hermeking H Benzinger A (2006) 14-3-3 proteins in cell cycle regulation. Semin Cancer Biol 16, 183 192.
11. Takihara Y, Matsuda Y Hara J (2000) Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis 21, 2073 2077.
12. Balmain A, Gray J Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33 (Suppl. 238 244.
13. Mhawech P (2005) 14-3-3 proteins - an update. Cell Res 15, 228 236.
14. Gasco M, Bell AK, Heath V, Sullivan A, Smith P, Hiller L, Yulug I, Numico G, Merlano M, Farrell PJ et al. (2002) Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16 (INK4a) silencing and human papillomavirus negativity. Cancer Res 62, 2072 2076.
15. Simooka H, Oyama T, Sano T, Horiguchi J Nakajima T (2004) Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis. Pathol Int 54, 595 602.
16. Urano T, Takahashi S, Suzuki T, Fujimura T, Fujita M, Kumagai J, Horie-Inoue K, Sasano H, Kitamura T, Ouchi Y et al. (2004) 14-3-3sigma is down-regulated in human prostate cancer. Biochem Biophys Res Commun 319, 795 800.
17. Laronga C, Yang HY, Neal C Lee MH (2000) Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 275, 23106 23112.
18. Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C Lee MH (2006) DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res 66, 3096 3105.
19. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW Vogelstein B (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1, 3 11.
20. Rohaly G, Chemnitz J, Dehde S, Nunez AM, Heukeshoven J, Deppert W Dornreiter I (2005) A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell 122, 21 32.
21. Sang M, Li Y, Ozaki T, Ono S, Ando K, Yamamoto H, Koda T, Geng C Nakagawara A (2006) p73-dependent induction of 14-3-3sigma increases the chemo-sensitivity of drug-resistant human breast cancers. Biochem Biophys Res Commun 347, 327 333.
22. Aprelikova O, Pace AJ, Fang B, Koller BH Liu ET (2001) BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J Biol Chem 276, 25647 25650.
23. Sugiyama A, Miyagi Y, Komiya Y, Kurabe N, Kitanaka C, Kato N, Nagashima Y, Kuchino Y Tashiro F (2003) Forced expression of antisense 14-3-3beta RNA suppresses tumor cell growth in vitro and in vivo. Carcinogenesis 24, 1549 1559.
24. Shumway SD, Li Y Xiong Y (2003) 14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin. J Biol Chem 278, 2089 2092.